DHP India (531306)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trading below book value: P/B of 0.82 against book value of ₹878.73 per share.
• Low headline P/E of 2.17 and PEG of 0.09 suggest statistically cheap earnings.
• Reported ROE of 28.77% is high, and Piotroski score of 6/9 shows moderate financial health.
• Profit growth of 25.51% despite falling sales indicates some earnings resilience or non-operating support.

Concerns

• Sales declined 12.20%, showing a shrinking top line.
• ROCE of just 3.43% is far below ROE, implying weak core operating returns on capital.
• Latest quarter net profit of ₹1 Cr on sales of ₹12 Cr does not align with the earnings level implied by a P/E of 2.17.
• Dividend yield of 0.77% is low, offering little income support while waiting for a turnaround.

AI Analysis

At ₹723.80, DHP India sells at 0.82 times book value and a P/E of 2.17. On the surface, this is exactly the kind of Benjamin Graham bargain I look for. But I have learned that a low price-to-book is only as good as the assets behind it and the earnings power of those assets. The reported ROE of 28.77% is impressive, yet ROCE is merely 3.43%. That gap is a warning sign: the operating business is not generating a strong return on total capital employed. The profits may be coming from non-operating sources or one-time items rather than from selling oil equipment and services. Sales are down 12.20%, while profits rose 25.51%—I get suspicious when earnings grow while the top line shrinks. The latest quarter tells the real story: sales of ₹12 Cr and net profit of just ₹1 Cr. That scale of profit is nowhere near the earnings implied by a P/E of 2.17. So either the trailing earnings figure is distorted, or the quarterly number is not representative. The stock is at the top of its 52-week range, so the market has already discovered it. With a dividend yield of only 0.77%, I am not being paid to wait. DHP India is in a cyclical industry. At this price, I am not buying a clear compounding machine; I am buying a possible asset-backed cyclical at a discount. The Piotroski score of 6/9 is decent, but it does not override the weak operating returns. I would wait for better evidence that the core business has stabilized and that earnings are actually repeatable. Mr. Market is offering a headline cheap price, but I prefer a good business at a fair price over a questionable business at a statistical bargain.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer